CN113444770B - Construction method and application of single-cell transcriptome sequencing library - Google Patents

Construction method and application of single-cell transcriptome sequencing library Download PDF

Info

Publication number
CN113444770B
CN113444770B CN202010233568.3A CN202010233568A CN113444770B CN 113444770 B CN113444770 B CN 113444770B CN 202010233568 A CN202010233568 A CN 202010233568A CN 113444770 B CN113444770 B CN 113444770B
Authority
CN
China
Prior art keywords
sequencing
transposase
library
single cell
pcr
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN202010233568.3A
Other languages
Chinese (zh)
Other versions
CN113444770A (en
Inventor
万瑛
于海礼
仇鑫
陈钢
郑子寒
倪青山
周逸文
许昊
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Third Military Medical University TMMU
Original Assignee
Third Military Medical University TMMU
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Third Military Medical University TMMU filed Critical Third Military Medical University TMMU
Priority to CN202010233568.3A priority Critical patent/CN113444770B/en
Priority to PCT/CN2020/096320 priority patent/WO2021189679A1/en
Publication of CN113444770A publication Critical patent/CN113444770A/en
Application granted granted Critical
Publication of CN113444770B publication Critical patent/CN113444770B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1096Processes for the isolation, preparation or purification of DNA or RNA cDNA Synthesis; Subtracted cDNA library construction, e.g. RT, RT-PCR
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6806Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
    • CCHEMISTRY; METALLURGY
    • C40COMBINATORIAL TECHNOLOGY
    • C40BCOMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B50/00Methods of creating libraries, e.g. combinatorial synthesis
    • C40B50/06Biochemical methods, e.g. using enzymes or whole viable microorganisms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Plant Pathology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

The invention belongs to the technical field of biology, and particularly discloses a construction method and application of a single-cell transcriptome sequencing library. The method comprises the following steps: lysing the sorted single cells in an orifice plate, and performing reverse transcription by using a reverse transcription primer to synthesize first strand cDNA; synthesizing a second strand cDNA using a substitution synthesis reaction; fragmenting the double-stranded cDNA using Tn5 transposase; enriching the fragmented templates by PCR; and (3) labeling the enriched fragments by using Index PCR, and purifying to obtain a single cell transcriptome sequencing library. The invention directly carries out enzyme digestion on double-stranded cDNA by using Tn5 transposase, does not need to carry out PCR pre-amplification on cDNA, can reduce library preference and obtain more accurate transcriptome information; meanwhile, tn5 transposase is used, so that the library construction efficiency can be improved, and the library construction time can be shortened. The method has simple library construction steps, can detect more genes, effectively reduces the proportion of the low-abundance genes dropout, reduces the library construction time and cost, and is favorable for finer research on a single cell level.

Description

Construction method and application of single-cell transcriptome sequencing library
Technical Field
The invention relates to the field of biotechnology, in particular to the field of single-cell sequencing, and particularly relates to a construction method and application of a single-cell transcriptome sequencing library.
Background
In the last decade, RNA sequencing (RNA-seq) technology has been rapidly developed, and has become an indispensable tool for research such as differential gene expression, mRNA splicing analysis and the like, and has been widely applied in the biomedical field. The existing RNA-seq methods are mostly based on cell populations, the results of which reflect only the average expression level of genes in multicellular populations and cannot exhibit differences in gene expression in each cell. The recently developed single-cell RNA-seq is a novel technology for sequencing RNA at the single cell level, can effectively solve the problems of cell heterogeneity of a tissue sample and transcriptome heterogeneity of cell populations covered by conventional RNA-seq, provides a novel research direction for analyzing the behavior, mechanism and relation with organisms of single cells, and becomes a novel approach for single-cell research.
At present, a single-cell RNA library construction method generally needs to pre-amplify a small amount of RNA in a single cell, such as reverse transcription of the RNA into cDNA, and then PCR amplification is carried out on two ends of the cDNA by adding known sequences, or in vitro transcription and amplification are carried out on the cDNA by using an IVT technology, but the two library construction modes cannot avoid the problems of uneven transcriptome coverage, large background noise, inaccurate quantification and the like caused by deviation introduced by PCR amplification; also, these methods can cause dropout, especially for genes with low and medium expression levels, due to loss of some transcripts during amplification and capture, which is important for analysis of gene-to-gene co-expression and contribution of low and medium expression genes to biological pathways. Most single cell transcriptome sequencing methods such as SCRB-Seq, drop-Seq, etc., although detecting a larger number of cells, only sequencing the 3' end of the transcript, with each cell detecting a smaller number of genes; the Smart-Seq method can amplify full-length cDNA by using template conversion, so that the gene detection quantity is increased, but the quantity of detected cells is small, the steps are complex, and compared with other methods, the cost is higher. In addition, the traditional ultrasonic and enzyme digestion fragmentation library construction method needs to realize library construction through complex steps such as terminal repair, splicing and the like. In order to be able to obtain efficiently accurate transcriptome characteristics of single cells, it is necessary to develop a new single cell transcriptome sequencing technique.
Disclosure of Invention
Aiming at the problems, the invention provides a construction method of a single-cell transcriptome sequencing library and application thereof, which can quickly and effectively construct a single-cell transcriptome, and the invention uses Tn5 transposase to directly carry out DNA fragmentation and connection reaction on double-stranded cDNA, does not need to carry out PCR pre-amplification on the cDNA, and can quickly and efficiently construct the single-cell transcriptome sequencing library. The method can detect more genes, effectively reduce the proportion of the low-abundance genes dropout, obtain more accurate transcriptome information, and reduce the time and cost of library establishment.
To achieve the above and other related objects, a first aspect of the present invention provides a method for constructing a single cell transcriptome sequencing library, comprising the steps of:
(a) Lysing the sorted single cells in an orifice plate;
(b) Reverse transcription is carried out by utilizing a reverse transcription primer to synthesize a first strand eDNA;
(c) Synthesizing a second strand cDNA using a substitution synthesis reaction;
(d) Fragmenting the double-stranded cDNA template with Tn5 transposase;
(e) Enriching the fragmented templates by PCR;
(f) The enrichment fragments are labeled by Index PCR, and a single cell transcriptome sequencing library which can be directly used for sequencing is obtained after the product is purified.
Further, in step (a), the single cells are cultured cells in vitro, tissue cells, and free cells in body fluids; the single cell is derived from one of any tissues of human beings, rats and mice; the single cells were sorted to lysate by flow cytometry and lysed on ice for 15 minutes to fully lyse the cells.
Further, in the step (b), the reverse transcription primer is an immobilization structure of TTTTTTTTTTTTTTTTTTTTTTTTTTTTTTVN in order of 5 'to 3', which is used for specific binding to poly (A) tail of mRNA to ensure specificity of reverse transcription. Regarding the specific sequence and length range of the above-mentioned reverse transcription primer, those skilled in the art can design and use according to actual needs.
Further, in step (b), the reverse transcriptase used in reverse transcription is selected from one of Superscript II reverse transcriptase, superscript such as t III reverse transcriptase or Superscript IV reverse transcriptase.
Further, in step (c), the second strand cDNA synthesis reagent used was NEBNext Ultra II Non-Directional RNA Second Strand Module kit from New England Biolabs.
Further, in the step (d), the Tn5 transposase is an In-House Tn5 transposase, and the preparation method of the In-House Tn5 transposase comprises the following steps: transforming bacteria with Tn5 recombinant plasmid, performing IPTG induced expression, crushing thalli, and purifying Tn5 transposase protein by using a Ni column; and transferring the assembly into a protein ultrafiltration concentration tube for ultrafiltration purification to obtain the Tn5 transposase. The In-House Tn5 transposase obtained by the method has the characteristics of good purity and high activity, and has high library construction efficiency.
Further, in the step (e), primer sequences used in the process of enriching the template by PCR are Read1 and Read2 sequences which are universal to an Illumina sequencing platform, and the Read1 sequence is shown as SEQ ID NO:21, the Read2 sequence is shown in SEQ ID NO: shown at 22.
Further, in step (e), the enriched template is purified by magnetic beads and then used for subsequent Index PCR, wherein the magnetic beads can be VAHTS DNA purification magnetic beads of Vazyme company or magnetic beads of the same type, and the magnetic beads and the enriched template are purified according to the ratio of 1:1.
Further, in step (f), one P5 and one P7 form a pair of primers that are adapted for Illumina sequencing platform sequencing, the primer sequences of P5 and P7 are as follows:
P5:AATGATACGGCGACCACCGAGATCTACAC[Index]TCGTCGGCAGCGTC,
P7:CAAGCAGAAGACGGCATACGAGAT[Index]GTCTCGTGGGCTCGG,
wherein Index is a nucleic acid sequence of 8bp in length. With respect to the specific sequence of Index, one skilled in the art can design a wider variety of classes for use as desired.
The second aspect of the invention provides application of the construction method of the single-cell transcriptome sequencing library in single-cell sequencing.
The third aspect of the invention provides a single-cell sequencing method, which comprises the steps of constructing a single-cell sequencing library by adopting the construction method of the single-cell transcriptome sequencing library, and then sequencing by adopting a high-throughput sequencing platform. Wherein, the high throughput sequencing platform is an Illumina sequencing platform.
The fourth aspect of the present invention provides a method for constructing the single-cell transcriptome sequencing library or the application of the single-cell sequencing method in preparing a detection kit, a detection device or a detection system for development research or cancer research.
As described above, the method for constructing the single cell transcriptome and the application thereof have the following beneficial effects:
compared with the existing Single cell sequencing technology, the scSTAT-seq (Single-cell Streamlined Transcription And Tagmentation Sequencing) technology directly performs enzyme digestion on double-stranded cDNA by using Tn5 transposase, does not need to perform PCR pre-amplification on a cDNA template, can effectively reduce library preference, and obtains more accurate transcriptome information; the In-House Tn5 transposase is used for synchronously completing DNA breaking and joint connection, so that the initial template quantity and sample processing time can be reduced, complex experimental operation is simplified, the library construction efficiency is effectively improved, and the library construction cost is reduced; the method has simple library construction steps, can detect more genes, effectively reduces the proportion of the low-abundance genes dropout, truly reflects the single-cell gene expression condition, is favorable for finer research on a single-cell level, and meets the requirement of single-cell sequencing development.
Drawings
FIG. 1 is a flowchart of the database creation according to an embodiment of the present invention.
FIG. 2 shows a library fragment profile of an embodiment of the invention.
FIG. 3 shows a graph of gene quantity distribution violin comparing the SMART-seq2 method according to the embodiment of the present invention.
FIG. 4 shows a sequencing saturation plot comparing the SMART-seq2 method of an embodiment of the present invention.
FIG. 5 shows a plot of the gene dropout of the present invention compared to the SMART-seq2 method.
Detailed Description
Other advantages and effects of the present invention will become apparent to those skilled in the art from the following disclosure, which describes the embodiments of the present invention with reference to specific examples. The invention may be practiced or carried out in other embodiments that depart from the specific details, and the details of the present description may be modified or varied from the spirit and scope of the present invention.
The library construction in the present invention was performed based on mouse monocyte macrophage leukemia cell RAW 264.7.
The main reagents, instruments and materials used in the present invention are shown in the following table 1.
TABLE 1
Figure BDA0002428168200000041
The specific implementation process is as follows:
in this embodiment, for example, single cell library construction of a 96-well plate is taken, for example, more single cells need to be subjected to library construction, and more Index PCR primers need to be designed and synthesized. The method for constructing the single cell transcriptome of the present invention is specifically described by the following steps:
1. lysing cells
1. The solution was formulated and dispensed into 96 wells according to the following composition:
1%CA630--------------------------------------------------0.6μl
rnase OUT ribonuclease inhibitor of 0.025. Mu.l
The method has the advantages that the method is convenient to use, and the device is easy to use
Deoxyribonucleoside triphosphate premix solution of 0.1 μl
The method is characterized in that the method comprises the following steps of
The method has the advantages that the method is convenient to use, and the device is suitable for being used for carrying out the process of the method
Wherein the reverse transcription primer is an immobilization structure of TTTTTTTTTTTTTTTTTTTTTTTTTTTTTTVN in order of 5 'to 3', which is used for specific binding to poly (A) tail of mRNA to ensure specificity of reverse transcription.
2. Single cells were sorted into 96-well plates using flow cytometry by re-suspending RAW 264.7 cells into PBS solution.
3. The cells were lysed on ice for 15 minutes.
2. Reverse transcription
1. The solution was formulated and dispensed into 96 wells containing lysed cells, the solution composition being as follows:
the utility model discloses a self-priming syringe for preventing and treating the fracture
The first chain buffer of the super-long buffer is used for preventing the first chain buffer from being damaged
Rnase OUT ribonuclease inhibitor (40 units/ul) - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -track) 0. - -2) 0.2. Mu.l)
SuperScript III reverse transcriptase (200 units/ul) - -, 0.2. Mu.l
The method has the advantages that the method is convenient to use, and the device is easy to use
The method has the advantages that the method is convenient to use, and the device is suitable for the users
2. Reverse transcription reaction was performed: 25℃for 10 minutes, 35℃for 10 minutes, 37℃for 10 minutes, 50℃for 60 minutes, 70℃for 15 minutes, 4 ℃.
3. Second strand cDNA Synthesis
1. A solution was prepared and dispensed into 96 wells containing reverse transcription product, the solution composition was as follows:
the method is characterized in that the method comprises the following steps of
The utility model discloses a new structure of the motor vehicle
The method has the advantages that the method is convenient to use, and the device is convenient to use
The method has the advantages that the method is convenient to use, and the device is suitable for being used for carrying out the process of the method
2. Second strand cDNA synthesis procedure was performed: the temperature was kept at 16℃for 60 minutes and 4 ℃.
4. Fragmentation of double-stranded cDNA template
1. A solution was prepared and dispensed into 96 wells containing double stranded cDNA, the solution composition was as follows:
the method is characterized in that the method comprises the following steps of
Tn5 transposase is 1 μl
The method is characterized in that the method comprises the following steps of
The method has the advantages that the method is convenient to use, and the device is easy to use
Wherein the Tn5 transposase is the In-House Tn5 transposase prepared In the laboratory, and the preparation method of the In-House Tn5 transposase is as follows: transforming bacteria with Tn5 recombinant plasmid, performing IPTG induced expression, crushing thalli, and purifying Tn5 transposase protein by using a Ni column; and transferring the assembly into a protein ultrafiltration concentration tube for ultrafiltration purification to obtain the Tn5 transposase with high activity and high purity.
2. And (3) performing a fragmentation procedure: the temperature is kept at 55 ℃ for 10 minutes and 10 ℃.
3. Immediately after completion of the fragmentation procedure, the reaction was stopped by adding 5. Mu.l of 0.2% SDS, and the mixture was blown and mixed with a pipette and left at room temperature for 5 minutes.
5. PCR enrichment of fragmented templates
1. A solution was prepared and dispensed into 96 wells of a buccal tablet segmentation template, the solution composition being as follows:
the method has the advantages that the method is convenient to use, and the device is convenient to use
The preparation method comprises the steps of
The method comprises the steps of (1) carrying out detection on the substances in the substrate, and (2) carrying out detection on the substances in the substrate
The method comprises the steps of (1) carrying out detection on the substances in the substances by using a detection device, and (2) carrying out detection on the substances in the substances by using a detection device
The method is characterized in that the method comprises the following steps of
The method has the advantages that the method is convenient to use, and the device is suitable for being used for carrying out the process of the method
2. Fragment PCR enrichment procedure was performed: 72℃for 3 minutes, 98℃for 30 seconds, 25 cycles (98℃for 15 seconds, 60℃for 30 seconds, 72℃for 3 minutes), 72℃for 5 minutes, 4℃hold.
3. Fragment purification: mu.l of VAHTS DNA purification beads were added to each well, and the mixture was stirred and stirred with a pipette and left at room temperature for 5 minutes. The supernatant was removed after the sample was placed on a magnet rack for minutes. Wash 2 times with 100 μl80% ethanol. Mu.l of nuclease-free water was added, and the mixture was blown and mixed with a pipette and left at room temperature for 5 minutes.
6. IndexPCR
1. A solution was prepared and dispensed into 96 wells containing magnetic bead purification templates, the solution composition was as follows:
KAPA Hot Start HiFi high Fidelity enzyme mixture-the utility model discloses a device for treating the skin of the patient
The method comprises the steps of (1) carrying out a process of preparing the composite material by using the composite material, and (2) carrying out a process of preparing the composite material
The method comprises the steps of (1) carrying out the process of detecting the presence of a metal catalyst, and (2) carrying out the process of detecting the presence of a metal catalyst
The method has the advantages that the method is convenient to use, and the device is suitable for being used for carrying out the process of the method
Wherein, one P5 and one P7 form a pair of primers, which are suitable for the sequencing of an Illumina sequencing platform, and 96 pairs of primers are used for Index labeling of 96-well cells.
The primer sequences for P5 and P7 are as follows:
P5:AATGATACGGCGACCACCGAGATCTACAC[Index]TCGTCGGCAGCGTC,
P7:CAAGCAGAAGACGGCATACGAGAT[Index]GTCTCGTGGGCTCGG。
where Index is a nucleic acid sequence of 8bp in length, those skilled in the art can design a wider variety of sequences for use as desired.
In the embodiment, the P5 and P7 primers are from an Illumina library building kit, the P5 primers comprise P501, P502, P503, P504, P505, P506, P507 and P508, and the sequences of the P501-P508 are shown as SEQ ID NO. 1-SEQ ID NO. 8; the P7 primer comprises P701, P702, P703, P704, P705, P706, P707, P708, P709, P710, P711 and P712, and the sequences of the P701-P712 are shown as SEQ ID NO. 9-SEQ ID NO. 20.
2. Index PCR procedure was performed: 95℃for 30 seconds, 15 cycles (98℃for 20 seconds, 60℃for 15 seconds, 72℃for 1 minute), 72℃for 5 minutes, 4℃hold.
3. Index PCR products in 96-well plates were aspirated and purified using QIAquick PCR purification kit to obtain a sequencing library compatible with the Illumina sequencing platform.
7. Sequencing the constructed library.
1. After the library purification was completed, the fragment distribution of the library was examined using Agilent Fragment Analyzer, and the results of the examination are shown in FIG. 2.
2. The library obtained above was sequenced using the Illumina X10 platform and compared to the SMART-seq2 library, and the sequencing results by bioinformatics analysis are shown in figures 3, 4, 5. The primer sequences used above are shown in Table 2.
TABLE 2 primer sequence listing
Figure BDA0002428168200000071
As can be seen from FIG. 3, an average of up to 9000 genes could be found in RAW 264.7 cells, an average of 3000 more than SMART-seq 2.
As can be seen from fig. 4, while the SMART-seq2 library (blue curve) is saturated at about 50 tens of thousands of reads/cell, the scSTAT-seq library (red curve) is saturated later; however, at the same depth, scSTAT-seq library detected about 2000 more genes on average than SMART-seq2 library.
From fig. 5, it can be seen that the scSTAT-seq library (blue curve) showed lower dropout levels than the SMART-seq2 library (red curve) in the linear regression analysis.
In summary, compared with the existing Single cell sequencing technology, the scSTAT-seq (Single-cell Streamlined Transcription And Tagmentation Sequencing) technology of the invention directly performs enzyme digestion on double-stranded cDNA by using Tn5 transposase without performing PCR pre-amplification on cDNA templates, thereby effectively reducing library preference and obtaining more accurate transcriptome information; the In-House Tn5 transposase is used for synchronously completing DNA breaking and joint connection, so that the initial template quantity and sample processing time can be reduced, complex experimental operation is simplified, the library construction efficiency is effectively improved, and the library construction cost is reduced; the method has simple library construction steps, can detect more genes, effectively reduces the proportion of the low-abundance genes dropout, truly reflects the single-cell gene expression condition, is favorable for finer research on a single-cell level, and meets the requirement of single-cell sequencing development.
The above embodiments are merely illustrative of the principles of the present invention and its effectiveness, and are not intended to limit the invention. Modifications and variations may be made to the above-described embodiments by those skilled in the art without departing from the spirit and scope of the invention. Accordingly, it is intended that all equivalent modifications and variations of the invention be covered by the claims, which are within the ordinary skill of the art, be within the spirit and scope of the present disclosure.
Figure BDA0002428168200000091
/>
Figure BDA0002428168200000101
/>
Figure BDA0002428168200000111
/>
Figure BDA0002428168200000121
/>
Figure BDA0002428168200000131
/>
Figure BDA0002428168200000141
/>
Figure BDA0002428168200000151
/>
Figure BDA0002428168200000161
/>
Figure BDA0002428168200000171
/>
SEQUENCE LISTING
<110> Chinese people's university of Legend army medical university
<120> construction method of single cell transcriptome sequencing library and application thereof
<130> PCQLJ203246
<160> 22
<170> PatentIn version 3.5
<210> 1
<211> 51
<212> DNA
<213> Artificial
<220>
<223> P501
<400> 1
aatgatacgg cgaccaccga gatctacact agatcgctcg tcggcagcgt c 51
<210> 2
<211> 51
<212> DNA
<213> Artificial
<220>
<223> P502
<400> 2
aatgatacgg cgaccaccga gatctacacc tctctattcg tcggcagcgt c 51
<210> 3
<211> 51
<212> DNA
<213> Artificial
<220>
<223> P503
<400> 3
aatgatacgg cgaccaccga gatctacact atcctcttcg tcggcagcgt c 51
<210> 4
<211> 51
<212> DNA
<213> Artificial
<220>
<223> P504
<400> 4
aatgatacgg cgaccaccga gatctacaca gagtagatcg tcggcagcgt c 51
<210> 5
<211> 51
<212> DNA
<213> Artificial
<220>
<223> P505
<400> 5
aatgatacgg cgaccaccga gatctacacg taaggagtcg tcggcagcgt c 51
<210> 6
<211> 51
<212> DNA
<213> Artificial
<220>
<223> P506
<400> 6
aatgatacgg cgaccaccga gatctacaca ctgcatatcg tcggcagcgt c 51
<210> 7
<211> 51
<212> DNA
<213> Artificial
<220>
<223> P507
<400> 7
aatgatacgg cgaccaccga gatctacaca aggagtatcg tcggcagcgt c 51
<210> 8
<211> 51
<212> DNA
<213> Artificial
<220>
<223> P508
<400> 8
aatgatacgg cgaccaccga gatctacacc taagccttcg tcggcagcgt c 51
<210> 9
<211> 47
<212> DNA
<213> Artificial
<220>
<223> P701
<400> 9
caagcagaag acggcatacg agattcgcct tagtctcgtg ggctcgg 47
<210> 10
<211> 47
<212> DNA
<213> Artificial
<220>
<223> P702
<400> 10
caagcagaag acggcatacg agatctagta cggtctcgtg ggctcgg 47
<210> 11
<211> 47
<212> DNA
<213> Artificial
<220>
<223> P703
<400> 11
caagcagaag acggcatacg agatttctgc ctgtctcgtg ggctcgg 47
<210> 12
<211> 47
<212> DNA
<213> Artificial
<220>
<223> P704
<400> 12
caagcagaag acggcatacg agatgctcag gagtctcgtg ggctcgg 47
<210> 13
<211> 47
<212> DNA
<213> Artificial
<220>
<223> P705
<400> 13
caagcagaag acggcatacg agataggagt ccgtctcgtg ggctcgg 47
<210> 14
<211> 47
<212> DNA
<213> Artificial
<220>
<223> P706
<400> 14
caagcagaag acggcatacg agatcatgcc tagtctcgtg ggctcgg 47
<210> 15
<211> 47
<212> DNA
<213> Artificial
<220>
<223> P707
<400> 15
caagcagaag acggcatacg agatgtagag aggtctcgtg ggctcgg 47
<210> 16
<211> 47
<212> DNA
<213> Artificial
<220>
<223> P708
<400> 16
caagcagaag acggcatacg agatcctctc tggtctcgtg ggctcgg 47
<210> 17
<211> 47
<212> DNA
<213> Artificial
<220>
<223> P709
<400> 17
caagcagaag acggcatacg agatagcgta gcgtctcgtg ggctcgg 47
<210> 18
<211> 47
<212> DNA
<213> Artificial
<220>
<223> P710
<400> 18
caagcagaag acggcatacg agatcagcct cggtctcgtg ggctcgg 47
<210> 19
<211> 47
<212> DNA
<213> Artificial
<220>
<223> P711
<400> 19
caagcagaag acggcatacg agattgcctc ttgtctcgtg ggctcgg 47
<210> 20
<211> 47
<212> DNA
<213> Artificial
<220>
<223> P712
<400> 20
caagcagaag acggcatacg agattcctct acgtctcgtg ggctcgg 47
<210> 21
<211> 33
<212> DNA
<213> Artificial
<220>
<223> Read1
<400> 21
tcgtcggcag cgtcagatgt gtataagaga cag 33
<210> 22
<211> 34
<212> DNA
<213> Artificial
<220>
<223> Read2
<400> 22
gtctcgtggg ctcggagatg tgtataagag acag 34

Claims (5)

1. A method for constructing a single cell transcriptome sequencing library, comprising the steps of:
(a) Lysing the sorted single cells in an orifice plate;
(b) Reverse transcription is carried out by using a reverse transcription primer to synthesize first-strand cDNA, wherein the reverse transcription primer is an immobilization structure which is TTTTTTTTTTTTTTTTTTTTTTTTTTTTTTVN in sequence from 5 'to 3', the immobilization structure is used for carrying out specific binding with poly A tail of mRNA so as to ensure the specificity of reverse transcription, and reverse transcriptase used in reverse transcription is selected from one of Superscript II reverse transcriptase, superscript III reverse transcriptase and Superscript IV reverse transcriptase;
(c) Synthesizing second strand cDNA by substitution synthesis reaction, wherein the second strand cDNA synthesis reagent is NEBNext Ultra II Non-Directional RNASecond Strand Module kit of New England Biolabs company;
(d) Fragmenting the double-stranded cDNA template with Tn5 transposase;
(e) The method comprises the steps of enriching a fragmented template by using PCR, wherein primer sequences used in the process of enriching the template by using PCR are Read1 and Read2 sequences which are universal for an Illumina sequencing platform, the Read1 sequence is shown as SEQ ID NO. 21, and the Read2 sequence is shown as SEQ ID NO. 22; the enriched template is purified by magnetic beads and then is used for subsequent Index PCR, the magnetic beads are VAHTSDNA purified magnetic beads of Vazyme company or magnetic beads of the same type, and the magnetic beads and the enriched template are purified according to the proportion of 1:1;
(f) The enriched fragments were labeled using Index PCR, with one P5 and one P7 constituting a pair of primers that were adapted to Illumina sequencing platform sequencing, the primer sequences for P5 and P7 were as follows:
P5:AATGATACGGCGACCACCGAGATCTACAC-Index-TCGTCGGCAGCGTC,
P7:CAAGCAGAAGACGGCATACGAGAT-Index-GTCTCGTGGGCTCGG,
wherein Index is a nucleic acid sequence of 8bp in length;
the single cell transcriptome sequencing library directly used for sequencing is obtained after the product is purified.
2. The method according to claim 1, characterized in that: in the step (d), the Tn5 transposase is an In-House Tn5 transposase, and the preparation method of the In-House Tn5 transposase comprises the following steps: transforming bacteria with Tn5 recombinant plasmid, performing IPTG induced expression, crushing thalli, and purifying Tn5 transposase protein by using a Ni column; and transferring the assembly into a protein ultrafiltration concentration tube for ultrafiltration purification to obtain the Tn5 transposase.
3. Use of the method of construction of a single cell transcriptome sequencing library according to any of claims 1-2 in single cell sequencing.
4. A single cell sequencing method, wherein the single cell sequencing library is constructed by the single cell transcriptome sequencing library construction method according to any one of claims 1-2, and sequencing is performed by a high throughput sequencing platform.
5. Use of the method of construction of a single cell transcriptome sequencing library according to any of claims 1-2 or the single cell sequencing method according to claim 4 for the preparation of a detection kit, detection device or detection system for developmental or cancer research.
CN202010233568.3A 2020-03-27 2020-03-27 Construction method and application of single-cell transcriptome sequencing library Active CN113444770B (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
CN202010233568.3A CN113444770B (en) 2020-03-27 2020-03-27 Construction method and application of single-cell transcriptome sequencing library
PCT/CN2020/096320 WO2021189679A1 (en) 2020-03-27 2020-06-16 Method for constructing single cell transcriptome sequencing library and use thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202010233568.3A CN113444770B (en) 2020-03-27 2020-03-27 Construction method and application of single-cell transcriptome sequencing library

Publications (2)

Publication Number Publication Date
CN113444770A CN113444770A (en) 2021-09-28
CN113444770B true CN113444770B (en) 2023-05-30

Family

ID=77808240

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202010233568.3A Active CN113444770B (en) 2020-03-27 2020-03-27 Construction method and application of single-cell transcriptome sequencing library

Country Status (2)

Country Link
CN (1) CN113444770B (en)
WO (1) WO2021189679A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114107459B (en) * 2021-11-11 2022-12-06 浙江大学 High-throughput single cell sequencing method based on oligonucleotide chain hybridization marker
CN114350748A (en) * 2021-12-30 2022-04-15 厦门大学 Rapid single-cell library building method
WO2023155135A1 (en) * 2022-02-18 2023-08-24 深圳华大生命科学研究院 Construction method and sequencing method for single-cell transcriptome sequencing library and test kit for preparing single-cell transcriptome library
CN115386622B (en) * 2022-10-26 2023-10-27 北京寻因生物科技有限公司 Library construction method of transcriptome library and application thereof
CN115386624B (en) * 2022-10-26 2023-03-21 北京寻因生物科技有限公司 Single cell complete sequence marking method and application thereof
CN116536394A (en) * 2023-04-26 2023-08-04 青岛百创智能制造技术有限公司 Construction method of marine organism single cell transcriptome library
CN117683866A (en) * 2024-01-22 2024-03-12 湛江中心人民医院 Method for detecting DNA in cells

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017048993A1 (en) * 2015-09-15 2017-03-23 Takara Bio Usa, Inc. Methods for preparing a next generation sequencing (ngs) library from a ribonucleic acid (rna) sample and compositions for practicing the same
CN109811045A (en) * 2017-11-22 2019-05-28 深圳华大智造科技有限公司 The construction method of high-throughput unicellular overall length transcript profile sequencing library and its application

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4368715A2 (en) * 2015-08-28 2024-05-15 Illumina, Inc. Nucleic acid sequence analysis from single cells
CN106754904B (en) * 2016-12-21 2019-03-15 南京诺唯赞生物科技有限公司 The specific molecular label of cDNA a kind of and its application

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017048993A1 (en) * 2015-09-15 2017-03-23 Takara Bio Usa, Inc. Methods for preparing a next generation sequencing (ngs) library from a ribonucleic acid (rna) sample and compositions for practicing the same
CN109811045A (en) * 2017-11-22 2019-05-28 深圳华大智造科技有限公司 The construction method of high-throughput unicellular overall length transcript profile sequencing library and its application

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
Charles Cole等.Tn5Prime, a Tn5 based 5" capture method for single cell RNA-seq.《Nucleic Acids Research》.2018,第46卷(第10期),e62. *
Epigenetic Application of ATAC-Seq Based on Tn5 Transposase Purification Technology;Wangchun Li等;《Genetics Research》;20220811;第2022卷;8429207 *
Large-Scale Low-Cost NGS Library Preparation Using a Robust Tn5 Purification and Tagmentation Protocol;Bianca P. Hennig等;《G3-Genes Genomes Genetics》;20171108;第8卷(第1期);79-89 *
Tn5Prime, a Tn5 based 5" capture method for single cell RNA-seq;Charles Cole等;《Nucleic Acids Research》;20180314;第46卷(第10期);第2页右栏第2-3段,第3页右栏最后一段-第4页左栏第1-2段,Supplementary Table S1 *
基于工程化转座酶的少量细胞RNA-seq文库构建的研究;许昊等;《第三军医大学学报》;20190222;第41卷(第09期);摘要,第1.2.1-1.2.4节,表1 *
基于狂犬病毒标记神经环路单细胞测序系统的建立及应用;闫科技;《中国优秀硕士学位论文全文数据库农业科技辑(月刊)》;20190115(第01期);D050-665 *

Also Published As

Publication number Publication date
WO2021189679A1 (en) 2021-09-30
CN113444770A (en) 2021-09-28

Similar Documents

Publication Publication Date Title
CN113444770B (en) Construction method and application of single-cell transcriptome sequencing library
CN106754904B (en) The specific molecular label of cDNA a kind of and its application
EP2714938B1 (en) Methods of amplifying whole genome of a single cell
TW201321518A (en) Method of micro-scale nucleic acid library construction and application thereof
WO2022021279A1 (en) Multi-nucleic acid co-labeling support, preparation method therefor, and application thereof
CN105986324A (en) Construction method and application of cyclic small RNA library
CN110438121A (en) Connector, connector library and its application
CN108531475A (en) A kind of high throughput transcript profile library constructing method
WO2023098492A1 (en) Sequencing library construction method and application
CN111575348A (en) Metagenome library, and library construction method and application thereof
CN114507711A (en) Single cell transcriptome sequencing method and application thereof
WO2021018127A1 (en) Library creation method and application
CN116083529B (en) Method for targeted enrichment of DNA of genome target region and application thereof
CN115058490B (en) Primer combination for constructing microorganism targeted sequencing library and application thereof
WO2020259303A1 (en) Method for rapid construction of rna 3&#39;-end gene expression library
WO2020181191A2 (en) Methods for rapid dna extraction from tissue and library preparation for nanopore-based sequencing
Kapustina et al. Sensitive and accurate analysis of gene expression signatures enabled by oligonucleotide-labelled cDNA
CN109628440A (en) A kind of high-throughput banking process based on two-step pcr
CN111534512A (en) Reverse transcription primer pool and kit for removing ribosomal RNA and method for removing ribosomal RNA
US20240052412A1 (en) Method for detecting rna structure at whole transcriptome level and use thereof
CN114774514B (en) Library construction method and kit suitable for high-throughput targeted genome methylation detection
US20230094911A1 (en) Solid Supports and Methods for Depleting and/or Enriching Library Fragments Prepared from Biosamples
CN108060218A (en) The screening technique of the nucleic acid fragment of preset range in nucleic acid sequencing library
US20220380755A1 (en) De-novo k-mer associations between molecular states
Wu et al. Oocytes, a single cell and a tissue

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant